Literature DB >> 33880499

MicroRNAs as biomarkers of multimodal treatment for rectal cancer.

R M Waldron1, B M Moloney1, K Gilligan1, A J Lowery1, M R Joyce1, E Holian2, M J Kerin1, N Miller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33880499     DOI： 10.1093/bjs/znab111

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  2 in total

1.  MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer.

Authors:  Matthew G Davey; Gerard Feeney; Heidi Annuk; Maxwell Paganga; Emma Holian; Aoife J Lowery; Michael J Kerin; Nicola Miller
Journal:  Cancers (Basel)       Date:  2022-04-23       Impact factor: 6.575

2.  Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial.

Authors:  Matthew G Davey; Maire Caitlin Casey; Andrew McGuire; Ronan M Waldron; Maxwell Paganga; Emma Holian; John Newell; Helen M Heneghan; Ailbhe M McDermott; Maccon M Keane; Aoife J Lowery; Nicola Miller; Michael J Kerin
Journal:  Ann Surg       Date:  2022-07-25       Impact factor: 13.787
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.